Technical Reports   |   Journal Articles

Technical Reports

Optimizing Investments in the National HIV Responses of Indonesia and Thailand: a Report for World Health Organization South-east Asia Regional Office
Grantham K, Reagan D, Law M, Wilson DP (2016)
Optimizing HIV Investments in Armenia
(2015)
Value for Money in Ukraine’s HIV Response: Strategic Investment and Improved Efficiency
(2015)
Optimizing Investments in the Kyrgyz Republic’s HIV Response
(2015)
Optimizing Investments in Georgia’s HIV Response
(2015)
Optimizing investments in Belarus for the National HIV Response
(2015)
Optimizing Investments in Kazakhstan’s HIV Response
(2015)
Modelling an Optimised Investment Approach for Uzbekistan
Đurić P, Hamelmann C, Kerr CC, Wilson DP (2015)
Scaling up HIV treatment for MSM in Bangkok: what does it take? – a modelling and costing study
Zhang L, Phanuphak N, Henderson K, Nonenoy S, Srikaew S, Shattock A, Kerr CC, Omune B, van Griensven F, Osornprasop S, Oelrichs R, Ananworanich J, Wilson DP (2015)
Zambia's HIV response: Prioritised and strategic allocation of HIV resources for impact and sustainability
Masaki E, Fraser N, Haacker M, Obst M, Wootton R, Sunkutu R, Gorgens M, Gray RT, Shattock A, Kerr CC, Wilson DP (2015)
HIV Mathematical Modelling to Support Swaziland's Development of its HIV Investment Case
Kelly S, Shattock A, Kerr CC, Gama T, Nhlabatsi N, Zagatti G, Harimurti P, Wilson DP, Gorgens M (2014)
Evaluation of a Decade of DFID and World Bank Supported HIV and AIDS Programmes in Vietnam from 2003 to 2012
Zhang L, Maher L, Pham DQ, Higgs P, Anh ND, Duc BH Shattock A, Hoa DM, Wilson DP (2014)
Sudan's HIV Response: Value for Money in a Low-Level HIV Epidemic
Fraser N, Benedikt C, Obst M, Masaki E, Gorgens M, Stuart R, Shattock A, Gray RT, Kerr CC, Wilson DP (2014)
Niger's HIV Response: Targeted Investments for a Healthy Future
Fraser N, Cheikh N, Haacker M, Masaki E, Karamoko D, Gorgens M, Frescura L, Konan C, Kerr CC, Gray RT, Shattock A, Wilson DP (2014)
Return on Investment and Cost-Effectiveness of Harm Reduction Programmes in Malaysia
Naning H, Kerr CC, Kamarulzaman, Dahlui AM, Ng CW, Wilson DP (2014)
HIV Investment in Armenia: Analysis & Recommendations
Kerr CC, Wilson DP (2014)
HIV Resource Needs, Efficient Allocation and Resource Mobilization for Tajikistan
Duric P, Hammelmann C, Wilson DP, Kerr CC (2014)
HIV Resource Needs, Efficient Allocation and Resource Mobilization for the Republic of Belarus
Wilson DP, Yakusik A, Kerr CC, Avila C (2013)
Return on Investment of Needle-Syringe Programs in the Philippines
Wilson DP, Reyes J, Kerr CC, Gray RT (2013)
Return on Investment of HIV Prevention in Vietnam
Zhang L, Pham QD, Do MH, Kerr CC, Wilson DP (2012)
Assessment of the allocation of HIV funding in Indonesia.
R.T. Gray, J. Reyes, M. Nadjib, P. Harimurti, D.P. Wilson (2012)
Allocating HIV funding efficiently in Myanmar: analyses using the Optima HIV model.
J. Estill, Z. Barańczuk, I. Reporter, D. Wilson, K. Boonto, S. Osornprasop, E. Masaki, J. de Beyer. (2016)
Allocative Efficiency Analysis (HIV) 2015-2030 for Karnataka & Punjab –India.
(2016)
Public Health Foundation of India in collaboration with National AIDS Control Organisation, National Institute of Medical Statistics, and Burnet Institute, supported by the World Bank
Optimizing investments in Bulgaria’s HIV response.
(2016).
University College London, Burnet Institute, University of New South Wales, supported by the World Bank, Global Fund, UINAIDS and UNDP for the Government of Bulgaria.
Optimizing investments in the HIV response for FYR Macedonia.
(2015).
Optimizing Investments in Moldova’s HIV Response.
(2015).
Ukraine HIV Program Efficiency Study: Can Ukraine improve value for money in HIV service delivery?
D.P. Wilson, K. Razali, K. Henderson, L. Maher, J. Ellard, A. Shattock, I. Semini, E. Masaki, M. Gorgens. (2014).
National HIV Allocative Efficiency Analysis in Argentina.
(2016).
The World Bank Group.
National HIV Allocative Efficiency Analysis in Mexico.
(2016).
The World Bank Group.
Optimizando la Inversión del Plan de Respuesta de Colombia al VIH.
(2016).
The World Bank Group. [PDF]
Optimización de las inversiones para la respuesta al HIV en Perú.
(2016).
The World Bank Group. [PDF]
HIV Investment in Cote d’Ivoire: Optimized allocation of HIV resources for a sustainable and efficient HIV response.
(2016).
University of Bern (Z. Barańczuk, J. Estill), University of New South Wales and Burnet Institute (I. Reporter, A. Hussain, D. Kedziora, C. Kerr, D. Wilson), World Bank (Z. Shubber, E. Mziray). [PDF]
HIV investment in Senegal: Optimized allocation of HIV resources for a sustainable and efficient HIV response.
(2016).
University of Bern (Z. Barańczuk, J. Estill), University of New South Wales and Burnet Institute (I. Reporter, A. Hussain, D. Wilson), World Bank (Z. Shubber, E. Mziray). [PDF]
Optimizing Investments in Togo’s HIV Response.
(2016).
University College London, Burnet Institute, University of New South Wales, supported by the World Bank for the Government of Togo.
Ending AIDS in Johannesburg: An analysis of the status and scale-up towards HIV treatment and prevention targets.
(2016).
Burnet Institute, Optima Consortium for Decision Science, supported by the World Bank for the Gauteng Province Department of Health and South African Department of Health. [PDF]

Journal Articles

A no-brainer for ending AIDS: the case for a harm reduction decade
Cook C, Lines R, Wilson DP (2016)
Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization
Kerr CC, Stuart RM, Gray RT, Shattock A, Fraser-Hurt N, Benedikt C, Haacker M, Berdnikov M, Mahmood AM, Jaber SA, Gorgens M, Wilson DP (2015)
Reorienting the HIV Response in Niger Toward Sex Work Interventions: From Better Evidence to Targeted and Expanded Practice
Fraser N, Kerr CC, Harouna Z, Alhousseini Z, Cheikh N, Gray R, Shattock A, Wilson DP, Haacker M, Shubber Z, Masaki E, Karamoko D, Görgens M (2015)
Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study
Zhang L, Phanuphak N, Henderson K, Nonenoy S, Srikaew S, Shattock A, Kerr CC, Omune B, van Griensven F, Sutayut Osornprasop S, Robert Oelrichs R, Ananworanich J, Wilson DP (2015)
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JAC, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bärnighausen T, Bershteyn A, Bloom DE, Boily M-C, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DAMC, Wagner BG, White RG, Wilson DP, Zhang L, Bandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Easterbrook P, Hirnschall G, Hallett TB (2014)
Estimating the cost-effectiveness of needle-syringe programs in Australia.
Kwon JA, Anderson J, Kerr CC, Thein H-H, Zhang L, Iversen J, Dore GJ, Kaldor JM, Law MG, Maher L, Wilson D (2012)
In the interests of time: improving HIV allocative efficiency modeling via optimal time-varying allocations
A.J. Shattock, C.C. Kerr, R.M. Stuart, E. Masaki, N. Fraser, C. Benedikt, M. Gorgens, D.P. Wilson, R.T. Gray. (2016)
Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programs for seasonal migrant laborers.
S.L. Kelly, A.J. Shattock, C.C. Kerr, R.M. Stuart, A. Papoyan, T. Grigoryan, R. Hovhannisyan, S. Grigoryan, C. Benedikt, D.P. Wilson. (2016).

Copyright © 2015 by the Optima team. Terms and Conditions